Wellnex shelves low dose S3 move amid ‘remote’ chance of registration by Steve Jones June 11, 2024June 11, 2024 Wellnex Life has shelved plans to develop an over-the-counter cannabis product after concluding the chances of […]
Wellnex to launch range of cannabis medicine as more products enter market by Steve Jones June 5, 2024June 6, 2024
OMG announces strategic collaboration for fast-absorption CBD ahead of insomnia trial by Martin Lane April 3, 2024July 16, 2024
Promethean BioPharma joins over-the-counter CBD race by Martin Lane November 30, 2023December 1, 2023
New Zealand reclassifies low-dose CBD, paving the way for OTC sales by Martin Lane October 17, 2023April 30, 2024
Bod Science clinical trial ‘proves the efficacy of CBD’ for pharmacy sales by Steve Jones September 6, 2023September 7, 2023
